Andy Liu - Group CEO - CELLOMICS HOLDINGS

Mr. Liu is the Group CEO of Cellomics Holdings, the leader in liquid biopsy technology for cancer screening and precision diagnostics.

He has over 20+ years of biotech and healthcare technology experience holding several commercial executive positions. Mr Liu was previously the President of Basebit Technologies, CEO of CW Data Technologies. (A WuXi Apptec JV). and the President of Asia Pacific and China for IQVia a global data analytics company (IMS Health).

Andy has also spent many years with private equity firm TPG as an operator running TPG life sciences portfolio companies. He has spent many years with multinational companies such as Merck and UCB Pharma.

Andy has served as Board of Directors for ASTRI, Chairman of ASTRI FinTech Limited and Vice Chairman of HKBIO.